Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Int J Mol Sci. 2024 Oct 8;25(19):10807. doi: 10.3390/ijms251910807.
Na-K ATPase is an integral component of cardiac sarcolemma and consists of three major subunits, namely the α-subunit with three isoforms (α, α, and α), β-subunit with two isoforms (β and β) and γ-subunit (phospholemman). This enzyme has been demonstrated to transport three Na and two K ions to generate a trans-membrane gradient, maintain cation homeostasis in cardiomyocytes and participate in regulating contractile force development. Na-K ATPase serves as a receptor for both exogenous and endogenous cardiotonic glycosides and steroids, and a signal transducer for modifying myocardial metabolism as well as cellular survival and death. In addition, Na-K ATPase is regulated by different hormones through the phosphorylation/dephosphorylation of phospholemman, which is tightly bound to this enzyme. The activity of Na-K ATPase has been reported to be increased, unaltered and depressed in failing hearts depending upon the type and stage of heart failure as well as the association/disassociation of phospholemman and binding with endogenous cardiotonic steroids, namely endogenous ouabain and marinobufagenin. Increased Na-K ATPase activity in association with a depressed level of intracellular Na in failing hearts is considered to decrease intracellular Ca and serve as an adaptive mechanism for maintaining cardiac function. The slight to moderate depression of Na-K ATPase by cardiac glycosides in association with an increased level of Na in cardiomyocytes is known to produce beneficial effects in failing hearts. On the other hand, markedly reduced Na-K ATPase activity associated with an increased level of intracellular Na in failing hearts has been demonstrated to result in an intracellular Ca overload, the occurrence of cardiac arrhythmias and depression in cardiac function during the development of heart failure. Furthermore, the status of Na-K ATPase activity in heart failure is determined by changes in isoform subunits of the enzyme, the development of oxidative stress, intracellular Ca-overload, protease activation, the activity of inflammatory cytokines and sarcolemmal lipid composition. Evidence has been presented to show that marked alterations in myocardial cations cannot be explained exclusively on the basis of sarcolemma alterations, as other Ca channels, cation transporters and exchangers may be involved in this event. A marked reduction in Na-K ATPase activity due to a shift in its isoform subunits in association with intracellular Ca-overload, cardiac energy depletion, increased membrane permeability, Ca-handling abnormalities and damage to myocardial ultrastructure appear to be involved in the progression of heart failure.
钠-钾 ATP 酶是心肌细胞膜的一个组成部分,由三个主要亚基组成,即具有三种同工型(α、α 和 α)的α-亚基、具有两种同工型(β 和 β)的β-亚基和γ-亚基(磷叶肽)。该酶已被证明可转运三个 Na 和两个 K 离子以产生跨膜梯度,维持心肌细胞中的阳离子稳态,并参与调节收缩力的发展。钠-钾 ATP 酶是外源性和内源性强心糖苷和甾体的受体,也是调节心肌代谢以及细胞存活和死亡的信号转导器。此外,钠-钾 ATP 酶通过与该酶紧密结合的磷叶肽的磷酸化/去磷酸化而受到不同激素的调节。据报道,钠-钾 ATP 酶的活性在衰竭心脏中增加、不变和降低,这取决于心力衰竭的类型和阶段以及磷叶肽的结合/解离与内源性强心甾体(即内源性哇巴因和马林布根因)的结合。衰竭心脏中与细胞内 Na 水平降低相关的钠-钾 ATP 酶活性增加被认为可降低细胞内 Ca 并作为维持心脏功能的适应机制。与心肌细胞中 Na 水平升高相关的心脏糖苷对钠-钾 ATP 酶的轻度至中度抑制已知在衰竭心脏中产生有益作用。另一方面,衰竭心脏中与细胞内 Na 水平升高相关的钠-钾 ATP 酶活性显著降低已被证明导致细胞内 Ca 过载、心律失常的发生和心脏功能的降低。此外,心力衰竭中钠-钾 ATP 酶活性的状态取决于酶的同工型亚基的变化、氧化应激的发展、细胞内 Ca 过载、蛋白酶激活、炎性细胞因子的活性和肌膜脂质组成。有证据表明,心肌阳离子的明显改变不能仅基于肌膜改变来解释,因为其他 Ca 通道、阳离子转运体和交换体可能参与了这一事件。由于同工型亚基的改变与细胞内 Ca 过载、心脏能量耗竭、膜通透性增加、Ca 处理异常和心肌超微结构损伤相关,钠-钾 ATP 酶活性的显著降低似乎与心力衰竭的进展有关。